Back to CTNM

JOHNSON & JOHNSON → CTNM

JOHNSON & JOHNSON CTNM Position History

Contineum Therapeutics, Inc. • Healthcare

Quarters held
7
Latest value
$26.6M
Q3 2026
Peak value
$32.4M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$23.3M
Q3 2025$23.3M
Q4 2025$22.6M
Q4 2025$22.6M
Q1 2026$25.8M
Q2 2026$32.4M
Q3 2026$26.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$26.6M1.98M——
Q2 2026$32.4M1.98M——
Q1 2026$25.8M1.98M——
Q4 2025$22.6M1.98M——
Q4 2025$22.6M1.98M——
Q3 2025$23.3M1.98M——
Q3 2025$23.3M1.98M——

Other funds holding CTNM

Other JOHNSON & JOHNSON positions

PB

PROTAGONIST THERAPEUTICS INC

$345.1M
PB

PROTAGONIST THERAPEUTICS INC

$300.2M
PB

Protagonist Therapeutics Inc.

$258.1M
PB

Protagonist Therapeutics Inc.

$213.9M
PB

Protagonist Therapeutics Inc.

$213.9M
NNBXF

NANOBIOTIX

$212M
NNBXF

NANOBIOTIX

$175.2M
NNBXF

Nanobiotix S.A.

$173.6M